Vincent Charlon
Directeur Général chez Anergis SA
Provenance du réseau au premier degré de Vincent Charlon
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.
35
| Subsidiary | Biotechnology | 35 |
| Public Company | Pharmaceuticals: Major | 18 | |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland.
10
| Holding Company | Pharmaceuticals: Generic | 10 |
Tollys
 Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon.
5
| Holding Company | Hospital/Nursing Management | 5 |
Hesperion AG
 Hesperion AG Miscellaneous Commercial ServicesCommercial Services Hesperion AG provided clinical development services. The firm focused on establishing clinical development partnerships with medical device, biotech and pharmaceutical companies. The company headquartered in Allschwil, Switzerland,
4
| Extinct | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Vincent Charlon via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Operating Officer Director/Board Member Director/Board Member Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Basel | College/University | Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Director/Board Member Undergraduate Degree | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Director of Finance/CFO Chief Executive Officer Compliance Officer | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| NOVIMMUNE SA | Medical/Nursing Services | Chairman Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Doctorate Degree | |
AYOXXA Biosystems GmbH
 AYOXXA Biosystems GmbH BiotechnologyHealth Technology AYOXXA Biosystems GmbH operates as a biotechnology firm. Its lunaris technology is the optimal analysis platform for the pre-clinical and clinical development work. The firm offers In-situ encoded bead array, a multiplexed protein analysis platform that allows users to measure proteins and biomolecular analytes. The company was founded by Dieter Trau and Andreas Schmidt in 2010 and is headquartered in Cologne, Germany. | Biotechnology | Chairman Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| ANGIOGENEX, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | President Sales & Marketing | |
biolitec Pharma Ltd.
 biolitec Pharma Ltd. Medical SpecialtiesHealth Technology biolitec Pharma Ltd. produces and markets a photo technology platform for the treatment of head and neck cancer. Its product Foscan, is a porphyrin photosensitising device used for the treatment of head and neck cancer in patients who cannot be treated with other therapies. The company is headquartered in Dublin, Ireland. | Medical Specialties | President General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Syntex Laboratories, Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
Averion International Corp.
 Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Averion International Corp. provides clinical research services. It serves for pharmaceutical, biotechnology and medical device industries. The company mainly focuses on oncology, nephrology, dermatology and medical devices. The company was founded on April 22, 2002 and is headquartered in Southborough, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Chairman | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| BB BIOTECH AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Friends of Phelophepa Foundation | Chairman Chairman | ||
| Franklin & Marshall College | College/University | Undergraduate Degree Undergraduate Degree | |
Paul Sacher Stiftung
 Paul Sacher Stiftung Investment Trusts/Mutual FundsMiscellaneous Paul Sacher Stiftung operates an international research center for music. The firm also facilitates and supports scholarly research by granting access to its archive. In addition, it engages in the scholarly investigation and study of its holdings through projects and its own publications. The company was founded in 1973 and is headquartered in Basel, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Doctorate Degree | |
| Humer Foundation | Chairman Director/Board Member | ||
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Director/Board Member Comptroller/Controller/Auditor | |
| University of Bath | College/University | Doctorate Degree | |
| VECTURA GROUP | Pharmaceuticals: Major | Chief Executive Officer | |
UT Horizon /Venture Capital/
 UT Horizon /Venture Capital/ Investment ManagersFinance UT Horizon /Venture Capital/ (UT Horizon) is a venture capital subsidiary of The University of Texas at Austin founded in 2011 by Bryan T. Allinson. The firm is headquartered in Austin, Texas. | Investment Managers | Consultant / Advisor | |
AGI Therapeutics Plc
 AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
GlaxoSmithKline Research & Development Ltd.
 GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, GlaxoSmithKline Research & Development Ltd. is a British biopharma company that unites science, technology, and talent to get ahead of disease together. The company was founded in 1965 and is based in Brentford, UK. GSK's work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer and Shionogi as shareholders. The company is united to do better in various fields, from finance to communications, procurement to HR. GSK provides images and B-roll video for media use and has a privacy notice that applies to any individual who is a current or former registered shareholder of GSK plc. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| NUFORMIX PLC | Biotechnology | Chairman |
Statistiques
Internationale
| Etats-Unis | 21 |
| Suisse | 14 |
| Royaume-Uni | 7 |
| Allemagne | 6 |
| France | 3 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 315 |
| Corporate Officer/Principal | 209 |
| Chairman | 108 |
| Chief Executive Officer | 71 |
| President | 68 |
Relations les plus connectées
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Franz Humer | 45 |
| Anula Kusum Jayasuriya | 31 |
| Gerald Heinz Möller | 29 |
| Sten Verland | 28 |
| Phyllis Whiteley | 26 |
| Gottlieb A. Keller | 26 |
| Laurent Fischer | 23 |
| Guido Magni | 23 |
| Clive Meanwell | 21 |
| Domenico Scala | 20 |
| Russell Ellison | 20 |
| Simon Pedder | 19 |
| Robert G. Savage | 19 |
| Philippe Calais | 18 |
- Bourse
- Insiders
- Vincent Charlon
- Connexions Sociétés
